Caris Life Sciences (CAI) Return on Sales (2024 - 2026)

Caris Life Sciences' Return on Sales history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Sales rose 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 1.0% from the prior year.
• Return on Sales eased to 0.0% in Q1 2026 per CAI's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q4 2025 and bottomed at 0.01% in Q1 2025.
• The 3-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
• Biggest YoY gain for Return on Sales was 1 bps in 2025; the steepest drop was 0 bps in 2025.
• Year by year, Return on Sales stood at 0.0% in 2024, then jumped by 198 bps to 0.0% in 2025, then sank by 101 bps to 0.0% in 2026.
• Per Business Quant, the three latest CAI Return on Sales figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).